MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients

Abstract

Six-monthly MRI detects metastases from high-risk uveal melanoma before the onset of symptoms, enhancing any opportunities for early treatment of metastatic disease and clinical trial participation. Whether these actually result in prolongation of life, after taking lead-time bias into account, requires further investigation.